查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1179789

天然膠原蛋白市場：按來源（牛、家禽、家禽、海洋、其他）按應用（醫療保健和製藥、化妝品、其他）：2021-2031 年全球機會分析和行業預測

Native Collagen Market By Source (Bovine, Porcine, Poultry, Marine, Others), By Application (Healthcare and Pharmaceuticals, Cosmetics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 330 Pages | 商品交期: 2-3個工作天內

價格

預計2021年全球天然膠原蛋白市場規模將達到3.052億美元，2031年將達到5.551億美元，2022-2031年復合年增長率為6.2%。

膠原蛋白具有高度通用的特性，可廣泛用於各種工業應用，例如醫藥、化妝品、食品和飲料。 因此，預計膠原蛋白在製藥和化妝品行業的使用增加將推動對膠原蛋白產品的需求。

2021年化妝品應用將佔據24%以上的市場份額。 膠原蛋白是一種在動物有機體中發現的結構蛋白，可提供基本的結構支持。 它最常從哺乳動物和魚類的皮膚中提取。 膠原蛋白是一種天然保濕劑，具有滋潤皮膚的有趣特性，這就是為什麼它在學術界和化妝品行業都受到極大關注的原因。 基於膠原蛋白的護髮產品可有效改善頭髮稀疏和防止曬傷。 它還可以促進頭髮生長並滋潤頭皮。 天然膠原蛋白市場的參與者正在進行持續的研發活動以開發創新產品。 此外，通過採用來自海洋的天然膠原蛋白，積極開展擴大產品範圍的運動。 例如，COBIOSA 生產用於頭髮和皮膚護理應用的海洋天然膠原蛋白。

中國的老齡化速度比現代歷史上的大多數國家都快。 根據 2020 年人口普查，中國 18.7% 的人口年齡在 60 歲以上，13.5% 的人口超過 65 歲。 到2050年，預計退休人數將佔總人口的39%。 在印度，國家人口委員會的一份報告估計，到 2021 年該國將有近 1.38 億老年人居住。 因此，老年人口的增長率高於一般人口。 發展中國家的老年人口需要營養保健品，這增加了對天然膠原蛋白的需求。 生活在該地區的人們逐漸意識到天然膠原蛋白在老齡化社會中的重要性，這將推動市場需求。 公眾對天然膠原蛋白產品缺乏認識也阻礙了該地區的市場發展。 生活方式的快速變化和中產階級人均收入的增加也將對市場產生積極影響。

生活方式和飲食習慣的改變、西方飲食習慣的採用、對食品中功能成分的需求增加以及工業活動的增加導致對工藝改進的需求正在推動新興經濟體膠原蛋白市場的發展。 亞太地區、南非、中東、南美和東歐國家等新興國家為市場增長提供了極好的機會。

全球天然膠原蛋白市場按來源、應用和地區劃分。

按來源分類，分為牛、豬、家禽、海產和其他。 此外，根據應用，全球天然膠原蛋白市場分為醫療保健和藥品、化妝品等。 此外，醫療保健和製藥領域進一步細分為骨骼和關節重建、傷口敷料、組織再生等。

按地區劃分，我們調查了北美、歐洲、亞太地區和 LAMEA。 北美目前佔有最大份額，其次是亞太地區和歐洲。

內容

第一章介紹

第 2 章執行摘要

第 3 章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資領域
  • 波特的五力分析
  • 主要公司的定位
  • 市場動態
    • 司機
    • 約束因素
    • 機會
  • COVID-19 影響分析
  • 定價分析
  • 價值鏈分析
  • 關鍵法規分析

第 4 章天然膠原蛋白市場：按來源

  • 概覽
    • 市場規模和預測
  • 奶牛
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 豬肉
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 家禽
    • 主要市場趨勢、增長動力和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 海鮮
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 5 章天然膠原蛋白市場：按應用

  • 概覽
    • 市場規模和預測
  • 醫療保健和製藥
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：國家分析
    • 醫療保健/醫藥天然膠原蛋白市場：按最終用戶分類
      • 骨骼和關節重建的市場規模和預測：按地區
      • 骨骼和關節重建材料的市場規模和預測：按國家/地區分類
      • 傷口敷料的市場規模和預測：按地區
      • 傷口敷料的市場規模和預測：按國家/地區分類
      • 組織再生的市場規模和預測：按地區
      • 組織再生的市場規模和預測：按國家/地區分類
      • 其他市場規模和預測：按地區
      • 其他市場規模和預測：按國家/地區分類
  • 化妝品
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類
  • 其他
    • 主要市場趨勢、增長因素和機遇
    • 市場規模和預測：按地區
    • 市場分析：按國家/地區分類

第 6 章天然膠原蛋白市場：按地區

  • 概覽
    • 市場規模和預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模和預測：按原材料
    • 北美市場規模和預測：按應用分類
      • 北美保健和製藥天然膠原蛋白市場：按最終用戶分類
    • 北美市場規模和預測：按國家/地區分類
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲市場規模和預測：按來源分類
    • 歐洲市場規模和預測：按應用分類
      • 歐洲醫療保健和製藥業天然膠原蛋白市場：按最終用戶分類
    • 歐洲市場規模和預測：按國家/地區分類
      • 德國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
  • 亞太地區
    • 主要趨勢和機會
    • 亞太市場規模和預測：按供應來源
    • 亞太地區的市場規模和預測：按應用分類
      • 亞太地區醫療保健和製藥業天然膠原蛋白市場：按最終用戶分類
    • 亞太地區的市場規模和預測：按國家/地區分類
      • 中國
      • 日本
      • 印度
      • 韓國
      • 其他亞太地區
  • 拉美
    • 主要趨勢和機會
    • LAMEA 市場規模和預測：按供應商分類
    • LAMEA 市場規模和預測：按應用分類
      • LAMEA Healthcare & Pharmaceutical 天然膠原蛋白市場：按最終用戶分類
    • LAMEA 市場規模和預測：按國家/地區分類
      • 拉丁美洲
      • 非洲
      • 中東

第七章商業條件

  • 簡介
  • 關鍵成功策略
  • 10 家主要公司的產品映射
  • 比賽儀表板
  • 競爭熱圖
  • 主要發展

第八章公司簡介

  • Creative Enzymes
  • Symatese
  • Vetoquinol S.A.
  • Bio-Rad Laboratories, Inc.
  • REPROCELL USA Inc.
  • Aviva Systems Biology Corporation
  • RayBiotech, Inc.
  • Cosmo Bio
  • Bioiberica S.A.U
  • Rockland Immunochemicals Inc.
  • Beyond Biopharma Co., Ltd.
  • TSI GROUP
Product Code: A31354

The global native collagen market size was valued at $305.2 million in 2021, and projected to reach $555.1 million by 2031, with a CAGR of 6.2% from 2022 to 2031.

Collagen has versatile properties that enable it to be extensively used in various industrial applications such as medical, cosmetics, and food & beverages. Hence, increasing application of collagen in the pharmaceutical and cosmetics industry is expected to fuel the demand for collagen products.

Cosmetics application accounted for over 24% of the market share in 2021. Collagen is a structural protein found in animal organisms where it provides for the fundamental structural support. Most commonly it is extracted from mammalian and fish skin. Collagen has attracted significant academic interest as well as the attention of the cosmetic industry due to its interesting properties that include being a natural humectant and moisturizer for the skin. Native collagen-based haircare products help reduce hair thinning and offer protection against sun damage. In addition, it promotes hair growth and boosts scalp hydration. The native collagen market players engage in continuous R&D activities to develop innovative products. They are also increasingly incorporating marine-based native collagen to boost product reach. For instance, COBIOSA produces native marine collagen for hair and skincare applications.

China population is aging faster than almost all countries in modern history. According to census released in 2020 18.7% of China population have people aged 60, and people aged 65 and above accounted for 13.5%. It is estimated that by 2050 the proportion of Chinese over retirement age will become 39% of the total population. In India, according to National Commission of Population report estimated that nearly 138 million elderly people are living in India in 2021. Thus, the growth rate of elderly population is higher than that of the general population. The presence of elderly people in developing countries require nutritional care and health care products increases the demand for native collagen. The gradual rise in awareness among the people living in this region regarding the importance of native collagen to aging people will drive the demand for market. In addition, lack of awareness among the people regarding the native collagen products is hampering the development of the market in this region. Moreover, rapid change in lifestyle and increase in per capita income of the middle class people will also have positive impact on the market.

Changing lifestyles, food habits, adoption of western food habits, an increase in demand for functional ingredients in food products, and an increase in industrial activity leading to the need for process enhancement have contributed to the development of the collagen market in emerging economies. Emerging economies such as the Asia Pacific, South Africa, the Middle East, South America, and Eastern European countries provide excellent opportunities for the growth of the market.

The global native collagen market is segmented on the basis of by source, application and region.

On the basis of source, it is segmented into bovine, porcine, poultry, marine, and others. In addition, on the basis of application, the global Native collagen market is segmented into healthcare and pharmaceuticals, cosmetics, and others. Furthermore, healthcare and pharmaceuticals segment is further bifurcated into bone and joint reconstruction, wound dressing, tissue regeneration, and others.

Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. Presently, North America accounts for the largest share of the market, followed by Asia-Pacific and Europe.

The major companies profiled in this report includes Aviva Systems Biology Corporation, Beyond Biopharma Co., Ltd., Bioiberica S.A.U., Bio-Rad Laboratories, Inc., Cosmo Bio, Creative Enzymes, RayBiotech, Inc., REPROCELL Inc., Rockland Immunochemicals Inc., Symatese, TSI Group Ltd., and Vetoquinol S.A. Additional growth strategies such as expansion of production capacities, acquisition, partnership and research & innovation in the extraction technologies have led to attain key developments in the global native collagen market trends.

Impact of COVID-19 on Global Native Collagen Market

The global COVID-19 pandemic has negative impact on the native collagen market. This market has experienced lower than anticipated demand across all regions compared to pre pandemic levels. The global market has exhibited a decline about 25% in 2020 compared to 2019 due to shutdown of various food processing industries and agricultural activities from where feedstock is used as raw material for the production.

The demand for products with a high nutritive value that offers multiple health benefits increases. Collagen is widely used in supplements targeted toward the aging population. The demand for collagen-based supplements by the aging population is anticipated to increase health, immunity, and overall wellness. Moreover, due to increasing health concerns due to pandemics, consumers now focus on food and beverage product labels. This is projected to provide ample opportunities for pharmaceuticals and healthcare products. The outbreak of pandemic is forecasted to affect the daily operations of collagen manufacturing due to restrictions on transportation and a shortage of laborers. However, the pandemic is anticipated to boost the sales of collagen during the study period, as it attracts attention from health-conscious consumers of different end products in which collagen is used, such as food, beverages, and nutritional products.

Post pandemic crisis, major collagen manufacturers have invested in the development of various products related to native collagen in cosmetics, pharmaceuticals, healthcare, and other sectors. Furthermore, the increase in awareness of the advantages of native collagen for elderly people due to pandemic outbreak have led to increase in the demand which will have positive impact on the market during the forecast period.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the native collagen market analysis from 2021 to 2031 to identify the prevailing native collagen market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the native collagen market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global native collagen market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Source

  • Bovine
  • Porcine
  • Poultry
  • Marine
  • Others

By Application

  • Healthcare and Pharmaceuticals
    • End Use
    • Bone and Joint Reconstruction
    • Wound Dressing
    • Tissue Regeneration
    • Others
  • Cosmetics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Spain
    • Rest Of Europe
    • Germany
    • France
    • Italy
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest Of Asia-Pacific
  • LAMEA
    • Latin America
    • Africa
    • Middle East
  • Key Market Players
    • Creative Enzymes
    • Symatese
    • Vetoquinol S.A.
    • Bio-Rad Laboratories, Inc.
    • REPROCELL USA Inc.
    • Aviva Systems Biology Corporation
    • RayBiotech, Inc.
    • Cosmo Bio
    • Bioiberica S.A.U
    • Rockland Immunochemicals Inc.
    • Beyond Biopharma Co., Ltd.
    • TSI GROUP

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Pricing Analysis
  • 3.8.Value Chain Analysis
  • 3.9.Key Regulation Analysis

CHAPTER 4: NATIVE COLLAGEN MARKET, BY SOURCE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Bovine
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Porcine
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Poultry
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Marine
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
  • 4.6 Others
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country

CHAPTER 5: NATIVE COLLAGEN MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Healthcare and Pharmaceuticals
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
    • 5.2.4 Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 5.2.4.1 Bone and Joint Reconstruction Market size and forecast, by region
      • 5.2.4.2 Bone and Joint Reconstruction Market size and forecast, by country
      • 5.2.4.3 Wound Dressing Market size and forecast, by region
      • 5.2.4.4 Wound Dressing Market size and forecast, by country
      • 5.2.4.5 Tissue Regeneration Market size and forecast, by region
      • 5.2.4.6 Tissue Regeneration Market size and forecast, by country
      • 5.2.4.7 Others Market size and forecast, by region
      • 5.2.4.8 Others Market size and forecast, by country
  • 5.3 Cosmetics
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Others
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: NATIVE COLLAGEN MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Source
    • 6.2.3 North America Market size and forecast, by Application
      • 6.2.3.1 North America Healthcare and Pharmaceuticals Native Collagen Market by End Use
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Source
      • 6.2.4.1.2 Market size and forecast, by Application
      • 6.2.4.1.2.1 U.S. Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Source
      • 6.2.4.2.2 Market size and forecast, by Application
      • 6.2.4.2.2.1 Canada Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Source
      • 6.2.4.3.2 Market size and forecast, by Application
      • 6.2.4.3.2.1 Mexico Healthcare and Pharmaceuticals Native Collagen Market by End Use
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Source
    • 6.3.3 Europe Market size and forecast, by Application
      • 6.3.3.1 Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Source
      • 6.3.4.1.2 Market size and forecast, by Application
      • 6.3.4.1.2.1 Germany Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Source
      • 6.3.4.2.2 Market size and forecast, by Application
      • 6.3.4.2.2.1 France Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.3.4.3 Italy
      • 6.3.4.3.1 Market size and forecast, by Source
      • 6.3.4.3.2 Market size and forecast, by Application
      • 6.3.4.3.2.1 Italy Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.3.4.4 Spain
      • 6.3.4.4.1 Market size and forecast, by Source
      • 6.3.4.4.2 Market size and forecast, by Application
      • 6.3.4.4.2.1 Spain Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.3.4.5 Rest of Europe
      • 6.3.4.5.1 Market size and forecast, by Source
      • 6.3.4.5.2 Market size and forecast, by Application
      • 6.3.4.5.2.1 Rest of Europe Healthcare and Pharmaceuticals Native Collagen Market by End Use
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Source
    • 6.4.3 Asia-Pacific Market size and forecast, by Application
      • 6.4.3.1 Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 China
      • 6.4.4.1.1 Market size and forecast, by Source
      • 6.4.4.1.2 Market size and forecast, by Application
      • 6.4.4.1.2.1 China Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.4.4.2 Japan
      • 6.4.4.2.1 Market size and forecast, by Source
      • 6.4.4.2.2 Market size and forecast, by Application
      • 6.4.4.2.2.1 Japan Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.4.4.3 India
      • 6.4.4.3.1 Market size and forecast, by Source
      • 6.4.4.3.2 Market size and forecast, by Application
      • 6.4.4.3.2.1 India Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.4.4.4 South Korea
      • 6.4.4.4.1 Market size and forecast, by Source
      • 6.4.4.4.2 Market size and forecast, by Application
      • 6.4.4.4.2.1 South Korea Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.4.4.5 Rest of Asia-Pacific
      • 6.4.4.5.1 Market size and forecast, by Source
      • 6.4.4.5.2 Market size and forecast, by Application
      • 6.4.4.5.2.1 Rest of Asia-Pacific Healthcare and Pharmaceuticals Native Collagen Market by End Use
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Source
    • 6.5.3 LAMEA Market size and forecast, by Application
      • 6.5.3.1 LAMEA Healthcare and Pharmaceuticals Native Collagen Market by End Use
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Latin America
      • 6.5.4.1.1 Market size and forecast, by Source
      • 6.5.4.1.2 Market size and forecast, by Application
      • 6.5.4.1.2.1 Latin America Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.5.4.2 Africa
      • 6.5.4.2.1 Market size and forecast, by Source
      • 6.5.4.2.2 Market size and forecast, by Application
      • 6.5.4.2.2.1 Africa Healthcare and Pharmaceuticals Native Collagen Market by End Use
      • 6.5.4.3 Middle East
      • 6.5.4.3.1 Market size and forecast, by Source
      • 6.5.4.3.2 Market size and forecast, by Application
      • 6.5.4.3.2.1 Middle East Healthcare and Pharmaceuticals Native Collagen Market by End Use

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Creative Enzymes
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 Symatese
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Vetoquinol S.A.
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 Bio-Rad Laboratories, Inc.
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 REPROCELL USA Inc.
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Aviva Systems Biology Corporation
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 RayBiotech, Inc.
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Cosmo Bio
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Bioiberica S.A.U
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Rockland Immunochemicals Inc.
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments
  • 8.11 Beyond Biopharma Co., Ltd.
    • 8.11.1 Company overview
    • 8.11.2 Company snapshot
    • 8.11.3 Operating business segments
    • 8.11.4 Product portfolio
    • 8.11.5 Business performance
    • 8.11.6 Key strategic moves and developments
  • 8.12 TSI GROUP
    • 8.12.1 Company overview
    • 8.12.2 Company snapshot
    • 8.12.3 Operating business segments
    • 8.12.4 Product portfolio
    • 8.12.5 Business performance
    • 8.12.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 2. GLOBAL NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 3. NATIVE COLLAGEN MARKET, FOR BOVINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 4. NATIVE COLLAGEN MARKET, FOR BOVINE, BY REGION, 2021-2031 (TONS)
  • TABLE 5. NATIVE COLLAGEN MARKET FOR BOVINE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. NATIVE COLLAGEN MARKET FOR BOVINE, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 7. NATIVE COLLAGEN MARKET, FOR PORCINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. NATIVE COLLAGEN MARKET, FOR PORCINE, BY REGION, 2021-2031 (TONS)
  • TABLE 9. NATIVE COLLAGEN MARKET FOR PORCINE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. NATIVE COLLAGEN MARKET FOR PORCINE, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 11. NATIVE COLLAGEN MARKET, FOR POULTRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. NATIVE COLLAGEN MARKET, FOR POULTRY, BY REGION, 2021-2031 (TONS)
  • TABLE 13. NATIVE COLLAGEN MARKET FOR POULTRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. NATIVE COLLAGEN MARKET FOR POULTRY, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 15. NATIVE COLLAGEN MARKET, FOR MARINE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. NATIVE COLLAGEN MARKET, FOR MARINE, BY REGION, 2021-2031 (TONS)
  • TABLE 17. NATIVE COLLAGEN MARKET FOR MARINE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 18. NATIVE COLLAGEN MARKET FOR MARINE, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 19. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
  • TABLE 21. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 23. GLOBAL NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 24. GLOBAL NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 25. NATIVE COLLAGEN MARKET, FOR HEALTHCARE AND PHARMACEUTICALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. NATIVE COLLAGEN MARKET, FOR HEALTHCARE AND PHARMACEUTICALS, BY REGION, 2021-2031 (TONS)
  • TABLE 27. NATIVE COLLAGEN MARKET FOR HEALTHCARE AND PHARMACEUTICALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 28. NATIVE COLLAGEN MARKET FOR HEALTHCARE AND PHARMACEUTICALS, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 29. GLOBAL HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 30. GLOBAL HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 31. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 32. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY REGION, 2021-2031 (TONS)
  • TABLE 33. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 34. NATIVE COLLAGEN MARKET, FOR BONE AND JOINT RECONSTRUCTION, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 35. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY REGION, 2021-2031 ($MILLION)
  • TABLE 36. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY REGION, 2021-2031 (TONS)
  • TABLE 37. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 38. NATIVE COLLAGEN MARKET, FOR WOUND DRESSING, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 39. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 40. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY REGION, 2021-2031 (TONS)
  • TABLE 41. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 42. NATIVE COLLAGEN MARKET, FOR TISSUE REGENERATION, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 43. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 44. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
  • TABLE 45. NATIVE COLLAGEN MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 46. NATIVE COLLAGEN MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 47. NATIVE COLLAGEN MARKET, FOR COSMETICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 48. NATIVE COLLAGEN MARKET, FOR COSMETICS, BY REGION, 2021-2031 (TONS)
  • TABLE 49. NATIVE COLLAGEN MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 50. NATIVE COLLAGEN MARKET FOR COSMETICS, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 51. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 52. NATIVE COLLAGEN MARKET, FOR OTHERS, BY REGION, 2021-2031 (TONS)
  • TABLE 53. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 54. NATIVE COLLAGEN MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 55. NATIVE COLLAGEN MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 56. NATIVE COLLAGEN MARKET, BY REGION, 2021-2031 (TONS)
  • TABLE 57. NORTH AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 58. NORTH AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 59. NORTH AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. NORTH AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 61. NORTH AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 62. NORTH AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 63. NORTH AMERICA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 64. NORTH AMERICA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 65. U.S. NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 66. U.S. NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 67. U.S. NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 68. U.S. NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 69. U.S. HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 70. U.S. HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 71. CANADA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 72. CANADA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 73. CANADA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 74. CANADA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 75. CANADA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 76. CANADA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 77. MEXICO NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 78. MEXICO NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 79. MEXICO NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. MEXICO NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 81. MEXICO HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 82. MEXICO HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 83. EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 84. EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 85. EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 86. EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 87. EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 88. EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 89. EUROPE NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 90. EUROPE NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 91. GERMANY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 92. GERMANY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 93. GERMANY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 94. GERMANY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 95. GERMANY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 96. GERMANY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 97. FRANCE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 98. FRANCE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 99. FRANCE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 100. FRANCE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 101. FRANCE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 102. FRANCE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 103. ITALY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 104. ITALY NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 105. ITALY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 106. ITALY NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 107. ITALY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 108. ITALY HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 109. SPAIN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 110. SPAIN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 111. SPAIN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 112. SPAIN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 113. SPAIN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 114. SPAIN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 115. REST OF EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 116. REST OF EUROPE NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 117. REST OF EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 118. REST OF EUROPE NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 119. REST OF EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 120. REST OF EUROPE HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 121. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 122. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 123. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 124. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 125. ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 126. ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 127. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 128. ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 129. CHINA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 130. CHINA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 131. CHINA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 132. CHINA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 133. CHINA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 134. CHINA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 135. JAPAN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 136. JAPAN NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 137. JAPAN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 138. JAPAN NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 139. JAPAN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 140. JAPAN HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 141. INDIA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 142. INDIA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 143. INDIA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 144. INDIA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 145. INDIA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 146. INDIA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 147. SOUTH KOREA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 148. SOUTH KOREA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 149. SOUTH KOREA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 150. SOUTH KOREA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 151. SOUTH KOREA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 152. SOUTH KOREA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 153. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 154. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 155. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 156. REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 157. REST OF ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 158. REST OF ASIA-PACIFIC HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 159. LAMEA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 160. LAMEA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 161. LAMEA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 162. LAMEA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 163. LAMEA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 164. LAMEA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 165. LAMEA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 166. LAMEA NATIVE COLLAGEN MARKET, BY COUNTRY, 2021-2031 (TONS)
  • TABLE 167. LATIN AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 168. LATIN AMERICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 169. LATIN AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 170. LATIN AMERICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 171. LATIN AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 172. LATIN AMERICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 173. AFRICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 174. AFRICA NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 175. AFRICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 176. AFRICA NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 177. AFRICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 178. AFRICA HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 179. MIDDLE EAST NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 ($MILLION)
  • TABLE 180. MIDDLE EAST NATIVE COLLAGEN MARKET, BY SOURCE, 2021-2031 (TONS)
  • TABLE 181. MIDDLE EAST NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 182. MIDDLE EAST NATIVE COLLAGEN MARKET, BY APPLICATION, 2021-2031 (TONS)
  • TABLE 183. MIDDLE EAST HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 ($MILLION)
  • TABLE 184. MIDDLE EAST HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET, BY END USE, 2021-2031 (TONS)
  • TABLE 185.CREATIVE ENZYMES: COMPANY SNAPSHOT
  • TABLE 186.CREATIVE ENZYMES: OPERATING SEGMENTS
  • TABLE 187.CREATIVE ENZYMES: PRODUCT PORTFOLIO
  • TABLE 188.CREATIVE ENZYMES: NET SALES,
  • TABLE 189.CREATIVE ENZYMES: KEY STRATERGIES
  • TABLE 190.SYMATESE: COMPANY SNAPSHOT
  • TABLE 191.SYMATESE: OPERATING SEGMENTS
  • TABLE 192.SYMATESE: PRODUCT PORTFOLIO
  • TABLE 193.SYMATESE: NET SALES,
  • TABLE 194.SYMATESE: KEY STRATERGIES
  • TABLE 195.VETOQUINOL S.A.: COMPANY SNAPSHOT
  • TABLE 196.VETOQUINOL S.A.: OPERATING SEGMENTS
  • TABLE 197.VETOQUINOL S.A.: PRODUCT PORTFOLIO
  • TABLE 198.VETOQUINOL S.A.: NET SALES,
  • TABLE 199.VETOQUINOL S.A.: KEY STRATERGIES
  • TABLE 200.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 201.BIO-RAD LABORATORIES, INC.: OPERATING SEGMENTS
  • TABLE 202.BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 203.BIO-RAD LABORATORIES, INC.: NET SALES,
  • TABLE 204.BIO-RAD LABORATORIES, INC.: KEY STRATERGIES
  • TABLE 205.REPROCELL USA INC.: COMPANY SNAPSHOT
  • TABLE 206.REPROCELL USA INC.: OPERATING SEGMENTS
  • TABLE 207.REPROCELL USA INC.: PRODUCT PORTFOLIO
  • TABLE 208.REPROCELL USA INC.: NET SALES,
  • TABLE 209.REPROCELL USA INC.: KEY STRATERGIES
  • TABLE 210.AVIVA SYSTEMS BIOLOGY CORPORATION: COMPANY SNAPSHOT
  • TABLE 211.AVIVA SYSTEMS BIOLOGY CORPORATION: OPERATING SEGMENTS
  • TABLE 212.AVIVA SYSTEMS BIOLOGY CORPORATION: PRODUCT PORTFOLIO
  • TABLE 213.AVIVA SYSTEMS BIOLOGY CORPORATION: NET SALES,
  • TABLE 214.AVIVA SYSTEMS BIOLOGY CORPORATION: KEY STRATERGIES
  • TABLE 215.RAYBIOTECH, INC.: COMPANY SNAPSHOT
  • TABLE 216.RAYBIOTECH, INC.: OPERATING SEGMENTS
  • TABLE 217.RAYBIOTECH, INC.: PRODUCT PORTFOLIO
  • TABLE 218.RAYBIOTECH, INC.: NET SALES,
  • TABLE 219.RAYBIOTECH, INC.: KEY STRATERGIES
  • TABLE 220.COSMO BIO: COMPANY SNAPSHOT
  • TABLE 221.COSMO BIO: OPERATING SEGMENTS
  • TABLE 222.COSMO BIO: PRODUCT PORTFOLIO
  • TABLE 223.COSMO BIO: NET SALES,
  • TABLE 224.COSMO BIO: KEY STRATERGIES
  • TABLE 225.BIOIBERICA S.A.U: COMPANY SNAPSHOT
  • TABLE 226.BIOIBERICA S.A.U: OPERATING SEGMENTS
  • TABLE 227.BIOIBERICA S.A.U: PRODUCT PORTFOLIO
  • TABLE 228.BIOIBERICA S.A.U: NET SALES,
  • TABLE 229.BIOIBERICA S.A.U: KEY STRATERGIES
  • TABLE 230.ROCKLAND IMMUNOCHEMICALS INC.: COMPANY SNAPSHOT
  • TABLE 231.ROCKLAND IMMUNOCHEMICALS INC.: OPERATING SEGMENTS
  • TABLE 232.ROCKLAND IMMUNOCHEMICALS INC.: PRODUCT PORTFOLIO
  • TABLE 233.ROCKLAND IMMUNOCHEMICALS INC.: NET SALES,
  • TABLE 234.ROCKLAND IMMUNOCHEMICALS INC.: KEY STRATERGIES
  • TABLE 235.BEYOND BIOPHARMA CO., LTD.: COMPANY SNAPSHOT
  • TABLE 236.BEYOND BIOPHARMA CO., LTD.: OPERATING SEGMENTS
  • TABLE 237.BEYOND BIOPHARMA CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 238.BEYOND BIOPHARMA CO., LTD.: NET SALES,
  • TABLE 239.BEYOND BIOPHARMA CO., LTD.: KEY STRATERGIES
  • TABLE 240.TSI GROUP: COMPANY SNAPSHOT
  • TABLE 241.TSI GROUP: OPERATING SEGMENTS
  • TABLE 242.TSI GROUP: PRODUCT PORTFOLIO
  • TABLE 243.TSI GROUP: NET SALES,
  • TABLE 244.TSI GROUP: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.NATIVE COLLAGEN MARKET SEGMENTATION
  • FIGURE 2.NATIVE COLLAGEN MARKET,2021-2031
  • FIGURE 3.NATIVE COLLAGEN MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.NATIVE COLLAGEN MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.PRICING ANALYSIS
  • FIGURE 13.VALUE CHAIN ANALYSIS
  • FIGURE 14.KEY REGULATION ANALYSIS
  • FIGURE 15.NATIVE COLLAGEN MARKET,BY SOURCE,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BOVINE NATIVE COLLAGEN MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PORCINE NATIVE COLLAGEN MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF POULTRY NATIVE COLLAGEN MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF MARINE NATIVE COLLAGEN MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS NATIVE COLLAGEN MARKET,2021-2031(%)
  • FIGURE 21.NATIVE COLLAGEN MARKET,BY APPLICATION,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE AND PHARMACEUTICALS NATIVE COLLAGEN MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF COSMETICS NATIVE COLLAGEN MARKET,2021-2031(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS NATIVE COLLAGEN MARKET,2021-2031(%)
  • FIGURE 25.NATIVE COLLAGEN MARKET BY REGION,2021
  • FIGURE 26.U.S. NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 27.CANADA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 28.MEXICO NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 29.GERMANY NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 30.FRANCE NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 31.ITALY NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 32.SPAIN NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 33.REST OF EUROPE NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 34.CHINA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 35.JAPAN NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 36.INDIA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 37.SOUTH KOREA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 38.REST OF ASIA-PACIFIC NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 39.LATIN AMERICA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 40.AFRICA NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 41.MIDDLE EAST NATIVE COLLAGEN MARKET,2021-2031($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46.COMPETITIVE DASHBOARD
  • FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 48.CREATIVE ENZYMES.: NET SALES ,($MILLION)
  • FIGURE 49.SYMATESE.: NET SALES ,($MILLION)
  • FIGURE 50.VETOQUINOL S.A..: NET SALES ,($MILLION)
  • FIGURE 51.BIO-RAD LABORATORIES, INC..: NET SALES ,($MILLION)
  • FIGURE 52.REPROCELL USA INC..: NET SALES ,($MILLION)
  • FIGURE 53.AVIVA SYSTEMS BIOLOGY CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 54.RAYBIOTECH, INC..: NET SALES ,($MILLION)
  • FIGURE 55.COSMO BIO.: NET SALES ,($MILLION)
  • FIGURE 56.BIOIBERICA S.A.U.: NET SALES ,($MILLION)
  • FIGURE 57.ROCKLAND IMMUNOCHEMICALS INC..: NET SALES ,($MILLION)
  • FIGURE 58.BEYOND BIOPHARMA CO., LTD..: NET SALES ,($MILLION)
  • FIGURE 59.TSI GROUP.: NET SALES ,($MILLION)